CellaVision launches a complete workflow solution for low-volume hematology laboratories
CellaVision announces the launch of DIFF-Line by CellaVision, a new workflow solution for low-volume hematology laboratories, at AACC
27 Jul 2022CellaVision® has announced the launch of DIFF-Line™ by CellaVision, a new workflow solution for low-volume hematology laboratories, at the AACC convention in Chicago. DIFF-Line by CellaVision consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision DC-1, RAL® SmearBox, and RAL® StainBox.
- CellaVision DC-1 is a single-slide analyzer that automates and digitizes the process of analyzing peripheral blood smears. The analyzer has an automated microscope, a high-quality digital camera, and an advanced computer system that uses artificial intelligence to locate, digitally capture, and pre-classify cells from stained blood smears. The pre-classified cells are presented on a computer screen for review and verification. The CellaVision DC-1 was launched in 2019 and received FDA clearance in October 2020.
- RAL SmearBox produces high-quality peripheral blood smears. The automated instrument uses a patented consumable to produce smears directly from a closed whole sample tube. CellaVision introduced the RAL SmearBox to the market on July 27th, 2022.
- RAL StainBox stains blood smears consistently and by laboratory guidelines. The semi-automated instrument utilizes the bath method and guides the laboratory through a step-by-step staining process. Improved staining protocols contribute to ease of use and optimized DC-1 performance. The RAL StainBox uses MCDh methanol-free stains to ensure high stain quality and reproducibility while reducing staff exposure to toxic chemicals.
Simon Ostergaard, CellaVision CEO, comments on the launch: "DIFF-Line™ by CellaVision is a comprehensive solution for small labs that want to improve diagnostic certainty. With the acquisition of RAL Diagnostics, CellaVision can now offer a complete workflow for smearing, staining, and analyzing peripheral blood smears in hematology labs that handle a smaller amount of daily blood samples.”